Page 9 - Read Online
P. 9

Castán et al. Hepatoma Res 2017;3:1-17                               Hepatoma Research
           DOI: 10.20517/2394-5079.2015.62
                                                                                                  www.hrjournal.net
            Review                                                                              Open Access


           Radiological diagnosis of hepatocellular

           carcinoma in non-cirrhotic patients



           Alba Castán , Ylenia Navarro , Luis Sarría , Raquel Larrosa , Mario Serradilla , Alejandro Serrablo 2
                                                              1
                                               1
                      1
                                    1
                                                                              2
           1 Department of Radiology, Miguel Servet University Hospital, 50009 Zaragoza, Spain.
           2 Division of Hepato-Pancreato-Biliary, Department of Surgery, Miguel Servet University Hospital, 50009 Zaragoza, Spain.
           Correspondence to: Dr. Luis Sarría, Department of Radiology, Miguel Servet University Hospital, Paseo Isabel la Católica, 1-3, 50009 Zaragoza, Spain.
           E-mail: lsarriao@salud.aragon.es
           How to cite this article: Castán A, Navarro Y, Sarría L, Larrosa R, Serradilla M, Serrablo A. Radiological diagnosis of hepatocellular carcinoma in
           non-cirrhotic patients. Hepatoma Res 2017;3:1-17.
                                         ABSTRACT

            Article history:              Hepatocellular carcinoma (HCC) arising in non-cirrhotic livers is relatively rare. Compared
            Received: 05-11-2015          with HCC arising in cirrhotic livers they have some quirks. HCC in healthy livers are large
            Accepted: 17-10-2016          tumors at diagnosis, and are detected due to the onset of abdominal symptoms, outside of any
            Published: 12-01-2017         scheduled monitoring program. In non-cirrhotic patients, HCC has the same appearance as
                                          the classic image of cirrhotic HCC substrate. The presence of capsule, extensive intratumoral
            Key words:                    necrosis and typical behavior in the dynamic study after administration of intravenous contrast
            Hepatocellular carcinoma,     are present in most of the non-cirrhotic livers. In the presence of a suspicious lesion of HCC,
            non-cirrhotic liver,          we must assess the  existence  of underlying  chronic  liver  disease.  Ultrasound,  computed
            ultrasound,                   tomography, and conventional magnetic resonance are imaging techniques that have a high
            elastography,                 specificity for the diagnosis of cirrhosis, but exhibit low sensitivity for diagnosis in the early
            computed tomography,          stages of the disease. In recent years, new imaging methods are being developed to assess
            magnetic resonance            emerging liver fibrosis. In particular, in patients without chronic liver disease it is imperative to
                                          consider the differential diagnosis with other tumors that may settle in healthy livers with similar
                                          radiological characteristics as HCC. Therefore, in the presence of a lesion with pathognomonic
                                          radiological characteristics of HCC in the absence of cirrhosis, biopsy is required.


           INTRODUCTION                                       and there was an emergence of about 32,000 new
                                                              cases in the United States. [1]
           Primary liver cancer is the fifth most common cancer
           in men and the ninth most common cancer in women,   Up to 90% of primary liver tumors are hepatocellular
           assuming the second leading cause of cancer death   carcinoma (HCC). HCC has its origin in hepatocytes,
           worldwide.  Eighty-three percent of new cases occur   the  predominant  cells  of  the  liver  parenchyma.
                     [1]
           in developing countries, half of them in China. Its   Around 80-90% arises in a cirrhotic liver. The most
           incidence has increased in recent decades, especially   commonly  associated  risk  factors  are  chronic
           in  developed  countries.  In  2015  in  Spain,  the   infection with hepatitis B virus (HBV) and hepatitis C
           incidence was 5.172 cases per 100,000 population   virus (HCV). HBV is the most common cause of HCC

                                                                                              Quick Response Code:
                       This is an open access article distributed under the terms of the Creative Commons Attribution-
                       NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work
            non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.


            For reprints contact: service@oaepublish.com

                        © 2017 OAE Publishing Inc.  www.oaepublish.com                                     1
   4   5   6   7   8   9   10   11   12   13   14